International Clinical Practice Guideline of Traditional Chinese Medicine in Cerebral Palsy

Title: International Clinical Practice Guideline of Traditional Chinese Medicine in Cerebral Palsy
Edition: Original
Classification: Standard guideline
Field: Diagnosis and Treatment
Countries and regions: China
Guidelines users: It is suitable for clinicians involved in the practice of traditional Chinese medicine in cerebral palsy worldwide.
Evidence classification method: This Guideline uses the Delphi grading standard proposed by the International Sepsis Forum (ISF) in 2001 to determine the level of recommendation.
Development unit: XI'an TCM Hospital of Encephalopathy
Registration time: 2022-01-10
Registration number: IPGRP-2022CN024
Purpose of the guideline: The International Clinical Practice Guideline of Traditional Chinese Medicine in Cerebral Palsy was written to standardize the clinical diagnosis and treatment of cerebral palsy in traditional Chinese medicine (hereinafter referred to as TCM) pediatrics, to provide clinicians with strategies and methods for the standardized management of pediatric diseases in TCM, and to promote the improvement of clinical diagnosis and research level in TCM pediatrics. This Guideline is concise, practical, and operable, keeps in line with medical regulations and legal requirements, has guidance, universality and reference value, and thus can be used as an important reference basis for clinical practice, diagnostic standardization and quality evaluation.